These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19526865)

  • 1. [Influence of citalopram selective serotonin reuptake inhibitor on circadian rhytms of excretory function of the kidneys].
    Kushnir IH; Kokoshchuk HI
    Fiziol Zh (1994); 2009; 55(3):125-7. PubMed ID: 19526865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hydrocortison on the circadian rhythm of the kidney excretory function during long-term darkness].
    Kokoshchuk HI; Kushnir IH
    Fiziol Zh (1994); 2006; 52(4):47-50. PubMed ID: 16958216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.
    Gannon RL; Peglion JL; Millan MJ
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):887-97. PubMed ID: 19604677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.
    Eltayb A; Svensson TH; Ahlenius S
    Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents.
    Westrich L; Sprouse J; Sánchez C
    Physiol Behav; 2013 Feb; 110-111():42-50. PubMed ID: 23276605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adrenalectomy and corticosterone replacement on diurnal [3H]citalopram binding in rat midbrain.
    Kulikov A; Mormède P; Chaouloff F
    Neurosci Lett; 1997 Jan; 222(2):127-31. PubMed ID: 9111745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats.
    Millan MJ; Girardon S; Dekeyne A
    Psychopharmacology (Berl); 1999 Mar; 142(4):432-4. PubMed ID: 10229070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
    Kleijn J; Cremers TI; Hofland CM; Westerink BH
    Neurosci Res; 2011 Jul; 70(3):334-7. PubMed ID: 21420449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serotonin reuptake inhibitor citalopram suppresses activity in the neonatal rat barrel cortex in vivo.
    Akhmetshina D; Zakharov A; Vinokurova D; Nasretdinov A; Valeeva G; Khazipov R
    Brain Res Bull; 2016 Jun; 124():48-54. PubMed ID: 27016034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Psychopharmacology (Berl); 2007 Dec; 195(3):325-32. PubMed ID: 17694388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.
    Inoue T; Hashimoto S; Tsuchiya K; Izumi T; Ohmori T; Koyama T
    Eur J Pharmacol; 1996 Sep; 311(1):1-6. PubMed ID: 8884229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired spatial learning in the Morris water maze induced by serotonin reuptake inhibitors in rats.
    Majlessi N; Naghdi N
    Behav Pharmacol; 2002 May; 13(3):237-42. PubMed ID: 12122314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of centrally acting amitriptyline and citalopram on histamine-induced cardiovascular effects in rats.
    Irman-Florjanc T; Jochem J; Zwirska-Korczala K
    Inflamm Res; 2006 Apr; 55 Suppl 1():S71-2. PubMed ID: 16547805
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.
    Jensen JB; Jessop DS; Harbuz MS; Mørk A; Sánchez C; Mikkelsen JD
    J Neuroendocrinol; 1999 Jun; 11(6):465-71. PubMed ID: 10336728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
    Pollier F; Sarre S; Aguerre S; Ebinger G; Mormède P; Michotte Y; Chaouloff F
    Neuropsychopharmacology; 2000 Jan; 22(1):64-76. PubMed ID: 10633492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
    Millan MJ; Gobert A; Girardon S; Dekeyne A
    Eur J Pharmacol; 1999 Jan; 364(2-3):147-50. PubMed ID: 9932717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.